Title : Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile - Bautista-Aguilera_2018_J.Med.Chem_61_6937 |
Author(s) : Bautista-Aguilera OM , Budni J , Mina F , Medeiros EB , Deuther-Conrad W , Entrena JM , Moraleda I , Iriepa I , Lopez-Munoz F , Marco-Contelles J |
Ref : Journal of Medicinal Chemistry , 61 :6937 , 2018 |
Abstract : Bautista-Aguilera_2018_J.Med.Chem_61_6937 |
ESTHER : Bautista-Aguilera_2018_J.Med.Chem_61_6937 |
PubMedSearch : Bautista-Aguilera_2018_J.Med.Chem_61_6937 |
PubMedID: 29969030 |
Bautista-Aguilera OM, Budni J, Mina F, Medeiros EB, Deuther-Conrad W, Entrena JM, Moraleda I, Iriepa I, Lopez-Munoz F, Marco-Contelles J (2018)
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile
Journal of Medicinal Chemistry
61 :6937
Bautista-Aguilera OM, Budni J, Mina F, Medeiros EB, Deuther-Conrad W, Entrena JM, Moraleda I, Iriepa I, Lopez-Munoz F, Marco-Contelles J (2018)
Journal of Medicinal Chemistry
61 :6937